Clinical Trials Directory

Trials / Completed

CompletedNCT02800356

Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD

Subthreshold Laser Treatment for Reticular Pseudodrusen and Incipient Geographic Atrophy Secondary to Age - Related Macular Degeneration: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Ospedale San Raffaele · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

To evaluate the effectiveness of subthreshold laser treatment on retinal sensitivity in patients with reticular pseudodrusen and incipient Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD). Secondary objective is to investigate changes in best-corrected visual acuity, atrophy progression and safety.

Conditions

Interventions

TypeNameDescription
PROCEDURESubthreshold 577 nm yellow wavelength laser photo-coagulatorSubthreshold photocoagulation is a method in which the burn spots (treated areas) cannot be seen with biomicroscopy, on color fundus photograph, on Optical Coherence Tomography or Fluorescein Angiography when the subthreshold level is adequately set. Subthreshold photocoagulation can be considered to be truly minimally invasive or non-damaging photocoagulation. A term sometimes used is photo-thermal stimulation since the Retinal Pigment Epithelium (RPE) layer is heated and stimulated, but not destroyed. The threshold level output power is set to obtain barely visible burn at approximately 200 mW to 250 mW using the titration mode, and irradiation is conducted after switching over to Endpoint Management.

Timeline

Start date
2016-06-01
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2016-06-15
Last updated
2025-03-20
Results posted
2020-02-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02800356. Inclusion in this directory is not an endorsement.